Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab

نویسندگان

  • Anaïs Huwart
  • Florent Garrigues
  • Sandrine Jousse-Joulin
  • Thierry Marhadour
  • Dewi Guellec
  • Divi Cornec
  • Maelenn Gouillou
  • Alain Saraux
  • Valérie Devauchelle-Pensec
چکیده

BACKGROUND This study assessed inflammatory changes using ultrasound (US) and magnetic resonance imaging (MRI) in patients taking tocilizumab for polymyalgia rheumatica (PMR). METHODS Eighteen patients were included in the prospective open-label TENOR study and received three tocilizumab infusions, without corticosteroids. B-mode and power Doppler US and MRI (T1 and T2-short time inversion recuperation weighted sequences) of the hips and shoulders were performed at weeks 0, 2, and 12. Subacromial, trochanteric, and iliopsoas bursitis and intraarticular glenohumeral and coxofemoral effusions/synovitis were scored from 0 to 3. Changes over time and US-MRI correlations were evaluated. RESULTS At baseline, the proportions of shoulders and hips with bursitis were 93 and 100% by MRI and 61 and 13% by US; and the corresponding proportions for intraarticular effusions/synovitis were 100 and 100% by MRI and 57 and 53% by US. Imaging findings did not improve during the first two treatment weeks. From baseline to week 12, bursitis improved significantly at all four joints by MRI (P = 0.005) and US (P = 0.029) and intraarticular effusions/synovitis by US only (P = 0.001). The proportion of abnormalities that improved by week 12 was 42% by MRI and 37% by US. MRI detected bursitis in a larger proportion of hips (73% versus 13%) and US in a larger proportion of shoulders (57% versus 28%), whereas no difference was found for intraarticular effusions/synovitis. At baseline, agreement between US and MRI findings was poor. CONCLUSIONS US and MRI showed significant improvements in inflammatory lesions during tocilizumab treatment of PMR.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Teaching NeuroImages: Polymyalgia rheumatica and giant cell arteritis.

A 62-year-old woman presented with 4 months of neck, shoulder, and hip pain, morning stiffness, and elevated inflammatory markers compatible with polymyalgia rheumatica (PMR). Cervical spine imaging demonstrated ill-defined enhancement in posterior neck soft tissues (figure 1), consistent with interspinous bursitis. She reported right-sided headache. Brain magnetic resonance angiography demonst...

متن کامل

Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis.

OBJECTIVES One of the unresolved challenges posed in giant cell (temporal) arteritis (GCA) is the detection and monitoring of large-artery complications, particularly aortitis. Recent investigations support vascular magnetic resonance imaging (MRI) studies in this issue. We report our preliminary experience with this imaging technique in the study of the aorta and its proximal branches in patie...

متن کامل

Inflammatory changes of hip synovial structures in polymyalgia rheumatica.

OBJECTIVE To investigate the hip inflammatory lesions and to evaluate the accuracy of clinical examination compared to magnetic resonance imaging (MRI) in patients with polymyalgia rheumatica (PMR) with pelvic girdle symptoms. Secondary end-point was to evaluate the sensitivity and specificity of ultrasonography (US) compared to MRI in the assessment of hip lesions. METHODS Case-control study...

متن کامل

Tocilizumab for polymyalgia rheumatica: a first or second line?

To the Editor: In the open-label uncontrolled trial recently published in the Annals of the Rheumatic Diseases, Devauchelle-Pensec et al showed high efficacy of tocilizumab as a first-line treatment for polymyalgia rheumatica (PMR). Twenty patients with PMR were treated with three tocilizumab intravenous infusions at a dose of 8 mg/kg with 4-week intervals followed by oral prednisone. At 12 wee...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 20  شماره 

صفحات  -

تاریخ انتشار 2018